tirzepatide pdufa date FDA Approves Tirzepatide, A Potential Blockbuster Drug for Type 2 Diabetes tirzepatide pdufa date Eli Lilly's

Once prescribed, tirzepatide, known as Zepbound, is delivered right to your doorstep, ensuring continued support every step of the way

That dual designation is rare

SURPASS-2: The Only Head-to-Head Trial The SURPASS-2 trial (NEJM, 2021) is the most important study in this comparison because it directly tested tirzepatide against semaglutide in 1,879 patients with type 2 diabetes over 40 weeks

Steady-state plasma concentrations are reached after roughly four weeks of once-weekly dosing, per the FDA label, so four weeks is not arbitrary

But the receptors these drugs target and the effects that follow are different